GB004 in Adult Subjects With Active Ulcerative Colitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a Phase 1b, randomized, double-blind-, placebo-controlled, multi-center study to evaluate the safety, tolerability, and PK of GB004 in adult subjects with active ulcerative colitis. Target engagement and effect of GB004 on pharmacodynamic biomarkers will be assessed.
Epistemonikos ID: 93eb6b354f5882128282a2c44442690028be3fe9
First added on: May 22, 2024